HTD1801 (BUDCA) ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
93Primary biliary cholangitis1

93. Primary biliary cholangitis


Clinical trials : 282 Drugs : 245 - (DrugBank : 56) / Drug target genes : 35 - Drug target pathways : 113
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04604652
(ClinicalTrials.gov)
May 27, 202116/10/2020Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary CholangitisA Phase 2 Open Label, Proof of Concept Study of HTD1801 (BUDCA) in Adult Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to Standard Therapy - PRONTO-PBCPrimary Biliary Cholangitis;Primary Biliary Cirrhosis;Cholangitis;Cholestasis;Biliary Tract Diseases;Bile Duct StrictureDrug: HTD1801 (BUDCA)HighTide Biopharma Pty LtdNULLRecruiting18 Years75 YearsAll30Phase 2United States